Project: Every Child for Younger Patients With Cancer
- Conditions
- Interventions
- First Posted Date
- 2015-03-30
- Last Posted Date
- 2024-10-26
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 33000
- Registration Number
- NCT02402244
- Locations
- 🇺🇸
Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, United States
🇺🇸Henry Ford Health Saint John Hospital, Detroit, Michigan, United States
🇺🇸Children's Hospital of Alabama, Birmingham, Alabama, United States
Tretinoin and Arsenic Trioxide in Treating Patients With Untreated Acute Promyelocytic Leukemia
- Conditions
- Interventions
- First Posted Date
- 2015-01-15
- Last Posted Date
- 2024-11-07
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 158
- Registration Number
- NCT02339740
- Locations
- 🇺🇸
University of California Davis Comprehensive Cancer Center, Sacramento, California, United States
🇺🇸Rady Children's Hospital - San Diego, San Diego, California, United States
🇺🇸Naval Medical Center -San Diego, San Diego, California, United States
Selinexor in Treating Younger Patients With Recurrent or Refractory Solid Tumors or High-Grade Gliomas
- Conditions
- Interventions
- First Posted Date
- 2014-12-24
- Last Posted Date
- 2024-11-19
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 59
- Registration Number
- NCT02323880
- Locations
- 🇺🇸
Baylor College of Medicine/Dan L Duncan Comprehensive Cancer Center, Houston, Texas, United States
🇺🇸Seattle Children's Hospital, Seattle, Washington, United States
🇺🇸Dana-Farber Cancer Institute, Boston, Massachusetts, United States
Response and Biology-Based Risk Factor-Guided Therapy in Treating Younger Patients With Non-high Risk Neuroblastoma
- Conditions
- Interventions
- First Posted Date
- 2014-06-27
- Last Posted Date
- 2024-11-01
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 621
- Registration Number
- NCT02176967
- Locations
- 🇺🇸
Children's Healthcare of Atlanta - Arthur M Blank Hospital, Atlanta, Georgia, United States
🇺🇸Henry Ford Health Saint John Hospital, Detroit, Michigan, United States
🇺🇸Children's Hospital of Alabama, Birmingham, Alabama, United States
VEGF Receptor Tyrosine Kinase Inhibitor Axitinib in Children With Recurrent or Refractory Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2014-06-17
- Last Posted Date
- 2018-01-29
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 51
- Registration Number
- NCT02164838
- Locations
- 🇺🇸
Childrens Hospital of Orange County, Orange, California, United States
🇺🇸Children's Healthcare of Atlanta - Egleston, Atlanta, Georgia, United States
🇺🇸Seattle Children's Hospital, Seattle, Washington, United States
Intra-arterial Melphalan in Treating Younger Patients With Unilateral Retinoblastoma
- First Posted Date
- 2014-03-26
- Last Posted Date
- 2023-10-13
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 14
- Registration Number
- NCT02097134
- Locations
- 🇺🇸
UCSF Medical Center-Mission Bay, San Francisco, California, United States
🇺🇸M D Anderson Cancer Center, Houston, Texas, United States
🇺🇸UCSF Medical Center-Parnassus, San Francisco, California, United States
Combination Chemotherapy in Treating Younger Patients With Newly Diagnosed, Non-metastatic Desmoplastic Medulloblastoma
- Conditions
- Interventions
- First Posted Date
- 2013-12-23
- Last Posted Date
- 2023-01-09
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 26
- Registration Number
- NCT02017964
- Locations
- 🇺🇸
Arkansas Children's Hospital, Little Rock, Arkansas, United States
🇺🇸Connecticut Children's Medical Center, Hartford, Connecticut, United States
🇺🇸UCSF Benioff Children's Hospital Oakland, Oakland, California, United States
Imetelstat Sodium in Treating Younger Patients With Relapsed or Refractory Solid Tumors
- Conditions
- Interventions
- First Posted Date
- 2013-12-13
- Last Posted Date
- 2018-08-07
- Lead Sponsor
- Children's Oncology Group
- Registration Number
- NCT02011126
Genetic Biomarkers in Saliva Samples From Patients With Ewing Sarcoma
- First Posted Date
- 2013-06-12
- Last Posted Date
- 2016-07-14
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 1650
- Registration Number
- NCT01876303
- Locations
- 🇺🇸
Children's Oncology Group, Monrovia, California, United States
Busulfan, Cyclophosphamide, and Melphalan or Busulfan and Fludarabine Phosphate Before Donor Hematopoietic Cell Transplant in Treating Younger Patients With Juvenile Myelomonocytic Leukemia
- Conditions
- Interventions
- First Posted Date
- 2013-04-05
- Last Posted Date
- 2018-12-05
- Lead Sponsor
- Children's Oncology Group
- Target Recruit Count
- 30
- Registration Number
- NCT01824693
- Locations
- 🇺🇸
Rainbow Babies and Childrens Hospital, Cleveland, Ohio, United States
🇺🇸Mattel Children's Hospital UCLA, Los Angeles, California, United States
🇺🇸City of Hope Comprehensive Cancer Center, Duarte, California, United States